Vertex Stock Technical Analysis

VRTX
 Stock
  

USD 291.16  2.18  0.75%   

As of the 7th of July, Vertex Pharmaceutic has the Semi Deviation of 2.88, risk adjusted performance of 0.1182, and Coefficient Of Variation of 1235.83. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vertex Pharmaceutic, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Vertex Pharmaceutic, which can be compared to its competition. Please validate Vertex Pharmaceutic value at risk, as well as the relationship between the semi variance and kurtosis to decide if Vertex Pharmaceutic is priced more or less accurately, providing market reflects its prevalent price of 291.16 per share. Given that Vertex Pharmaceutic has jensen alpha of 0.3613, we advise you to double-check Vertex Pharmaceutic's current market performance to make sure the company can sustain itself at a future point.
  
Refresh

Vertex Pharmaceutic Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vertex, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Vertex
Vertex Pharmaceutic's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Vertex Pharmaceutic Analyst Consensus

Target PriceAdvice# of Analysts
259.89Buy19Odds
Vertex Pharmaceutic current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Vertex analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vertex stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vertex Pharmaceutic, talking to its executives and customers, or listening to Vertex conference calls.
Vertex Analyst Advice Details
Vertex Pharmaceutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceutic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceutic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Vertex Pharmaceutic Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vertex Pharmaceutic volatility. High ATR values indicate high volatility, and low values indicate low volatility.
.

Vertex Pharmaceutic Trend Analysis

Use this graph to draw trend lines for Vertex Pharmaceutic. You can use it to identify possible trend reversals for Vertex Pharmaceutic as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vertex Pharmaceutic price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Vertex Pharmaceutic Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Vertex Pharmaceutic applied against its price change over selected period. The best fit line has a slop of   0.06  , which means Vertex Pharmaceutic will continue generating value for investors. It has 122 observation points and a regression sum of squares at 131.31, which is the sum of squared deviations for the predicted Vertex Pharmaceutic price change compared to its average price change.

About Vertex Pharmaceutic Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vertex Pharmaceutic on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vertex Pharmaceutic based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vertex Pharmaceutic stock first instead of the macroeconomic environment surrounding Vertex Pharmaceutic. By analyzing Vertex Pharmaceutic's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vertex Pharmaceutic's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vertex Pharmaceutic specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2019 2021 2022 (projected)
Long Term Debt to Equity0.08850.05050.0518
Interest Coverage79.5449.1553.03

Vertex Pharmaceutic July 7, 2022 Technical Indicators

Most technical analysis of Vertex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vertex from various momentum indicators to cycle indicators. When you analyze Vertex charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Also, please take a look at World Market Map. Note that the Vertex Pharmaceutic information on this page should be used as a complementary analysis to other Vertex Pharmaceutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceutic price analysis, check to measure Vertex Pharmaceutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceutic is operating at the current time. Most of Vertex Pharmaceutic's value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceutic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vertex Pharmaceutic's price. Additionally, you may evaluate how the addition of Vertex Pharmaceutic to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Is Vertex Pharmaceutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceutic. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.19
Market Capitalization
73.9 B
Quarterly Revenue Growth YOY
0.22
Return On Assets
0.14
Return On Equity
0.25
The market value of Vertex Pharmaceutic is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceutic's value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceutic's market value can be influenced by many factors that don't directly affect Vertex Pharmaceutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceutic's value and its price as these two are different measures arrived at by different means. Investors typically determine Vertex Pharmaceutic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.